Thermo Fisher Scientific is eliminating 300 jobs at its Cambridge and Plainville locations, effective March 30. The Waltham-based life sciences firm cited shifts in customer timelines and utilization needs as reasons for the layoffs, The Boston Globe reported Feb. 3.
Supply Chain
The recent imposition of a 10% tariff on Chinese imports is expected to raise the cost of generic drugs in the U.S. and worsen ongoing drug shortages, NBC News reported Feb. 3.
Columbia, Md.-based MedStar Health has turned the recent national IV fluid shortage into an opportunity to reduce its reliance on these products, cutting usage by about half of preshortage levels, according to an Jan. 31 ASHP report.
Nova Biomedical issued an urgent software correction for its StatStrip Glucose and Glucose/Ketone Hospital Meter Systems after it found a defect that could transmit incorrect glucose and ketone results to hospital data management systems.
Baxter International's CEO, president and chair, José "Joe" Almeida, abruptly retired from the medtech company Feb. 3 after nine years at the helm.
President Donald Trump is set to impose tariffs on certain goods from Mexico, Canada and China beginning Feb. 1, White House Secretary Karoline Leavitt confirmed Jan. 31.
A group of senators has reintroduced legislation aimed at strengthening American supply chains.
Baxter has restarted all 10 manufacturing lines at its Marion, N.C., facility, which was heavily damaged by flooding from Hurricane Helene.
Private equity firm Bridgefield Capital has entered into a definitive agreement to acquire Royal Philips' emergency care business.
Tulsa, Okla.-based Saint Francis Health System saved more than $5.6 million in one year by optimizing its supply chain operations in partnership with healthcare supply improvement company Premier.